Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA

NCT03523117 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Iron Deficiency Anemia

Interventions

DRUG: Ferric carboxymaltose
DRUG: Ferrous Sulfate

Sponsor

American Regent, Inc.